Lord Jonathan T. MD - 07 Dec 2022 Form 4 Insider Report for BIOLASE, INC (BIOLQ)

Role
Director
Signature
/s/ Michael C. Carroll, attorney-in-fact for Jonathan T. Lord
Issuer symbol
BIOLQ
Transactions as of
07 Dec 2022
Net transactions value
-$2,653
Form type
4
Filing time
08 Dec 2022, 20:48:57 UTC
Previous filing
12 May 2022
Next filing
12 Jun 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOL Common Stock Sale $2,653 -3,537 -5.6% $0.7500* 59,925 07 Dec 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.